In the current report, we demonstrate that recruitment of CCR5-expressing leukocytes in the colon is essential for the onset and maintenance of inflammation in mouse models of colitis and that, maraviroc, a small molecule inhibitors of CCR5, protects against colitis development targeting CCR5-bearing leukocytes. The gene discussed is CCR5; the disease is colitis.